Skip to main content
logo
Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
8.96
-0.20 (-2.18%)
Mar 30, 2026, 10:47 AM EDT - Market open

Zevra Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
526509448272159305
Market Cap Growth
22.42%13.81%64.53%71.60%-48.00%499.98%
Enterprise Value
409.99381.19437.99247.5489.34193.79
Last Close Price
8.968.968.346.554.598.71
PE Ratio
6.616.64-3.66-5.04-5.88-4.13
Forward PE
18.3319.15----
PS Ratio
5.054.7818.969.9115.1610.64
PB Ratio
3.373.2911.284.392.112.40
P/TBV Ratio
3.323.329.733.752.112.04
P/FCF Ratio
--209.38-6.43-8.04-8.4329.50
P/OCF Ratio
--318.79-6.43-8.11-8.4729.21
EV/Sales Ratio
3.853.5818.559.018.546.76
EV/EBITDA Ratio
--6.47-5.43-5.09-2.1524.27
EV/EBIT Ratio
--6.06-5.03-4.99-2.1025.07
EV/FCF Ratio
--156.68-6.29-7.32-4.7518.75
Debt / Equity Ratio
0.410.411.510.700.180.01
Debt / EBITDA Ratio
-1.15-1.07-0.75-0.90-0.340.20
Debt / FCF Ratio
-25.98-25.98-0.87-1.29-0.750.15
Net Debt / Equity Ratio
-0.83-0.83-0.23-0.39-0.92-0.87
Net Debt / EBITDA Ratio
2.342.170.110.491.65-13.87
Net Debt / FCF Ratio
52.5352.530.130.713.65-10.71
Asset Turnover
0.460.460.130.190.080.40
Inventory Turnover
8.898.897.53---
Quick Ratio
5.465.462.351.157.5826.92
Current Ratio
5.685.682.531.187.7227.20
Return on Equity (ROE)
161.99%85.66%-207.75%-67.27%-41.11%-28.19%
Return on Assets (ROA)
-25.95%-28.28%-41.18%-34.49%-34.88%10.68%
Return on Invested Capital (ROIC)
-79.24%-86.35%-90.57%-96.78%-197.33%85.98%
Return on Capital Employed (ROCE)
-30.19%-32.32%-71.71%-49.13%-36.64%11.68%
Earnings Yield
14.43%15.07%-27.34%-19.85%-16.99%-24.23%
FCF Yield
-0.45%-0.48%-15.56%-12.44%-11.86%3.39%
Buyback Yield / Dilution
-23.81%-23.81%-30.46%-2.79%-15.87%-647.71%
Total Shareholder Return
-23.81%-23.81%-30.46%-2.79%-15.87%-647.71%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q